republic-os/legislation/us/states/in/2026/sb-262.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	INSPECT program.	Sets forth the circumstances in which a dispenser is not required to transmit certain information to the INSPECT program (program). Requires an opioid treatment program to, before reporting patient information to the program, comply with federal regulations in obtaining patient consent. Allows the board of pharmacy to disclose prescription drug monitoring program data to a representative of the Indiana department of health and the office of the secretary of family and social services for specified purposes.	us/states/in	Indiana General Assembly	2026	SB 262	Indiana SB 262 (2026)	bill	AGENCIES; Department of Health (IDOH) AGENCIES; Family and Social Services Administration (FSSA) AGENCIES; Professional Licensing Agency (PLA) HEALTH CARE FACILITIES; Pharmacies HEALTH CARE PROFESSIONALS; Pharmacists HEALTH; Prescription Drugs and Medications	enacted	Ed Charbonneau Lori Goss-Reaves Michael Crider	4	22	3	2026-01-08	2026-03-05	openstates	ocd-bill/4ff6780a-ae30-42b2-a9e6-8cdebe3eddf6	https://api.iga.in.gov/2026/bills/sb0262	52c38448dc3043432220d37b9cc9452a108f5ebf7368a23438537710d44b200e	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-in

Indiana SB 262 (2026) — INSPECT program.

Sets forth the circumstances in which a dispenser is not required to transmit certain information to the INSPECT program (program). Requires an opioid treatment program to, before reporting patient information to the program, comply with federal regulations in obtaining patient consent. Allows the board of pharmacy to disclose prescription drug monitoring program data to a representative of the Indiana department of health and the office of the secretary of family and social services for specified purposes.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Engrossed Senate Bill (H) (committee substitute) — source
2. Enrolled Senate Bill (S) (committee substitute) — source
3. Introduced Senate Bill (S) (committee substitute) — source
4. Senate Bill (S) (committee substitute) — source

Votes

• SB 262 - Goss-Reaves - 3rd Reading — 94–0 (pass) · lower
• SB 262 - Crider — 47–0 (pass) · upper
• SB 262 - Crider - 3rd Reading — 48–0 (pass) · upper

Sponsors

• Ed Charbonneau — primary (person)
• Lori Goss-Reaves — primary (person)
• Michael Crider — primary (person)
• Brad Barrett — cosponsor (person)
• Cindy Ledbetter — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2026-01-08 First reading: referred to Committee on Health and Provider Services reading-1, referral-committee
• 2026-01-08 Authored by Senator Crider
• 2026-01-15 Committee report: amend do pass, adopted committee-passage
• 2026-01-22 Senator Charbonneau added as second author
• 2026-01-26 Amendment #2 (Crider) prevailed; voice vote amendment-passage
• 2026-01-26 Second reading: amended, ordered engrossed reading-2
• 2026-01-28 Cosponsors: Representatives Barrett, Ledbetter
• 2026-01-28 Third reading: passed; Roll Call 127: yeas 48, nays 0 passage, reading-3, reading-3
• 2026-01-28 House sponsor: Representative Goss-Reaves
• 2026-01-29 Referred to the House referral
• 2026-02-02 First reading: referred to Committee on Public Health reading-1, referral-committee
• 2026-02-17 Committee report: amend do pass, adopted committee-passage
• 2026-02-19 Second reading: ordered engrossed reading-2
• 2026-02-23 Third reading: passed; Roll Call 312: yeas 94, nays 0 passage, reading-3, reading-3
• 2026-02-24 Motion to concur filed filing
• 2026-02-24 Returned to the Senate with amendments receipt
• 2026-02-25 Senate concurred with House amendments; Roll Call 287: yeas 47, nays 0
• 2026-02-27 Signed by the President of the Senate passage
• 2026-03-05 Signed by the Governor executive-signature
• 2026-02-27 Signed by the President Pro Tempore passage
• 2026-03-05 Public Law 133 became-law
• 2026-02-27 Signed by the Speaker passage

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/4ff6780a-ae30-42b2-a9e6-8cdebe3eddf6. Confidence: reported (aggregated from official Indiana legislature records).